[1]
2023. Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology. Swiss Medical Weekly. 153, 7 (Jul. 2023), 40113. DOI:https://doi.org/10.57187/smw.2023.40113.